This Award Notice opportunity from Department Of Defense was posted on August 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

LOPERAMIDE HYDROCHLORIDE CAPSULES

Awarded

SPE2DP26F9130Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0270

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Pharmaceutical Grade Salicylic Acid SupplyThis subcontract involves the supply of high-purity, pharmaceutical-grade salicylic acid to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work encompasses the chemical synthesis and purification of the acid to ensure it meets strict pharmaceutical standards for topical medical applications. All deliverables must be accompanied by SDS documentation and hold USP or equivalent pharmaceutical grade certifications. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance of the contract is designated for FPO 09564. Interested parties should note the response deadline of November 16, 2026, for this bulk supply requirement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-27-T-0266

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply of 300 mcg and 480 mcg Non-Safety SyringesThis subcontract involves the manufacture and supply of pre-filled non-safety syringes containing 300 mcg and 480 mcg medication for prime contractors supporting Department of Veterans Affairs pharmaceutical supply projects. The scope of work includes producing pharmaceutical dosages with unique NDC numbers and providing commercial packaging in both individual units and boxes of ten. Distribution of these labeled syringes is managed through the VA/DoD Pharmaceutical Prime Vendor Programs. The opportunity is associated with NAICS code 325412 and is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, with a response deadline set for December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Filgrastim Biosimilar (VA-27-00012533)

Solicitation # 36E79727R0001

The Department of Veterans Affairs, through the National Acquisition Center, is soliciting a contract for Filgrastim Biosimilar under solicitation number 36E79727R0001. This procurement is issued in commercial item format in accordance with FAR Part 12 and is managed by point of contact Dov Vysnia. The contract structure consists of an initial one-year period followed by four pre-priced one-year option periods. Distribution of the pharmaceutical products will be handled through the respective Pharmaceutical Prime Vendor Programs of the VA and the Department of Defense. The scope of work requires the provision of non-safety syringes in 300 mcg and 480 mcg dosages, which must be specifically labeled for use by patients or caregivers. Offerors are required to provide a unique NDC number and the exact product name as it appears on the label. Strict labeling guidelines mandate that the contractor's label be the only one on the product, prohibiting the placement of labels over existing ones, though the packaging must allow VA labels to adhere securely on top. Required commercial packaging includes individual syringes and boxes of ten syringes. Proposals must be submitted electronically via SAM.gov by December 15, 2026, at 2:30 PM Central Time.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Request for Information (RFI) - Specialty â€“ PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT

Solicitation # 36E79727Q0001

The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.

Nac Prime Vendor (36W797)

POSTED

DEADLINE

Assayed Liquid Human Serum Comprehensive Chemistry Control SupplyThis subcontract involves the supply of assayed liquid human serum-based comprehensive chemistry control for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The requirement is for 84 units of frozen diagnostic control material, specifically Level 3 control featuring over 50 analytes. All materials must have a minimum shelf life of 24 months and be packaged according to Medical Marking Standard No. 1. To ensure product integrity, the contractor must maintain a strict cold chain storage environment between -20 and -70 degrees Celsius. The performance of this contract will take place in APO 09227. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Antiseptic Prep Swab SupplierThis subcontract opportunity is for a supplier to manufacture and provide pre-saturated antiseptic swabs to prime contractors supporting Department of Defense medical supply chain projects. The scope of work includes the production of alcohol and Povidone-iodine prep swabs utilizing medical-grade applicators. All products must be individually wrapped, delivered in bulk quantities, and maintain FDA approval for medical-grade antiseptics with a guaranteed stability supporting a 36-month shelf life. Managed by the Medical Supply Chain MD Surg FSF, the contract is associated with NAICS code 325412 and specifies San Antonio as the place of performance. Interested parties must submit their responses by November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Hand Sanitizer (70% Ethyl Alcohol) SupplyThis subcontract involves the supply of unscented, waterless hand cleanser for prime contractors supporting the Department of Defense Medical Supply Chain. The requirement is for four packages of 70% ethyl alcohol base cleanser, with each package containing twenty-four 4 fl oz bottles. All products must adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring a 36-month shelf life with no more than five months elapsed upon delivery. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this contract will take place in Annville, Pennsylvania. Interested parties should note the response deadline of November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Medical Kitting and PackagingThis subcontract for Sterile Medical Kitting and Packaging supports prime contractors on DLA supply contracts for the Department of Defense Medical Supply Chain. The scope of work involves the assembly of instruments into kits, sterilization for single-use disposable requirements using industrial autoclaves, and final packaging. All deliverables must be marked according to Medical Marking Standard No. 1 and MIL-STD-2073-1E to ensure the delivery of completed, sterile, and sealed Dental Operative Kits. The project falls under NAICS code 325412 and is performed at a facility in FPO 34088-3000. Interested parties should note the response deadline of November 16, 2026, following the posting date of November 8, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

2 days ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency awarded contract SPE2DP26F9130 to DMS Pharmaceutical Group Inc on August 24, 2026, for a total price of 954.80 dollars. This award is a delivery order placed under the base administrative contract SPE2DX25D9900, which was issued by the DLA Troop Support Medical Supply Chain FSB on April 2, 2025. The base contract incorporates FAR Part 12 clauses and serves as a replacement for contract SPE2DX25D9383 under the overarching base contract SPE2DX25D9000. The specific scope of this delivery order is for the procurement of Loperamide Hydrochloride Capsules, identified by NSN 6505010666568 and PR 7018034595. The procurement falls under NAICS code 325412 and was processed through solicitation SPE2DX-24-R-0001. This federal action ensures the supply of essential pharmaceutical products to the Department of Defense.

General Info

DLA awarded DMS Pharmaceutical Group $954.80 for Loperamide Hydrochloride Capsules on August 24, 2026.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$954.8

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INC

Award Issued Date

08/24/2026, 12:00:00 AM UTC

Documents

award

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 24

Award Notice

AwardedAug 24

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2DP26F9130 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $954.80 Award Date: 08-24-2026 Delivery order under: SPE2DX25D9900 Line items: - LOPERAMIDE HYDROCHLORIDE CAPSULES (NSN/Part 6505010666568, PR 7018034595)